Aspire Biopharma
ASBP7.2453.95% ( +0.275 )
Aspire Biopharma (ASBP)
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms i...
- Open
- 6.920
- High
- 7.370
- Low
- 6.920
- Prev. Close
- 6.970
- Volume
- 11.30K
- Turnover
- 81.29K
- Avg Price
- 7.192
- Bid/Ask Ratio
- --
- Amplitude
- 6.46%
- 52wk High
- 1,050.360
- Volume Ratio
- 0.15
- Turnover Ratio
- 0.93%
News
- rttnews · Jul 21 at 10:25 PM
Top Biotech Gainers: WGRX Rebrands, PVLA Nears FDA Milestone, ASBP On Track For NDA Filing
- Tip Ranks · Jul 20 at 04:48 PM
Aspire Biopharma Updates Public Warrant Exercise Terms
- PUBT · Jul 20 at 04:21 PM
Aspire Biopharma says ASPBW warrants now carry exercise price of 13,800 per share after reverse splits
- PUBT · Jun 26 at 07:57 AM
Aspire Biopharma posts June 2026 investor presentation for on-demand viewing
- PUBT · Jun 24 at 07:30 AM
Aspire unit Buzz Bomb Caffeine launches BUZZ BOMB 50 mg caffeine stick packs on Amazon
- PUBT · Jun 23 at 09:59 AM
Aspire Biopharma posts investor deck on sublingual drug-delivery platform, lead sublingual aspirin program
